School of Life Sciences

Microbiology, Molecular Biology and Biochemistry MRes/Phd Supervisors

Fungal Biology MRes/Phd Supervisors
  • Paul Dyer (Fungal sexual development; Microbiology of fungal pathogens; Fungal human and plant pathogens; Evolution of antifungal resistance and development of novel antifungal compounds; Use of fungi in food production; Lichen biochemistry; Biotechnological applications of fungi) 

  • Simon Avery (Microbiology of fungal pathogens; Fungal human and plant pathogens; Evolution of antifungal resistance and development of novel antifungal compounds; Use of fungi in food production; Biotechnological applications of fungi)

  • Matthias Brock (Control of fungal pathogens; Fungal secondary metabolism; Fungal human and plant pathogens; Lichen biochemistry; Biotechnological applications of fungi)
 
Molecular Biology Supervisors
  • Ian Kerr (Mechanisms and structures of proteins involved in transmembrane flux)

  • Robert Layfield (Ubiquitin-mediated signalling and proteostasis; Paget's disease of bone - molecular mechanisms and ancient forms of the disorder; Neurodegenerative disorders - ALS and FTLD; Proteomic analyses - including of ancient proteins (paleoproteomics); Protein structure and function)

  • Nigel Minton (Clostridial gene technologies)

  • Christopher Penfold (Bacteriocin production by E. Coli; Anti-microbial peptides; Hybrid molecules)

  • Rita Tewari (Functional analysis of signalling pathways modulating malaria parasite development, cell division and parasite proliferation)

  • Uwe Vinkemeier (Cytokines; Signal transduction in myeloid cells)

  • Ying Zhang (strain engineering; bioproducts from renewable sources; synthetic biology approaches to generate novel strains with advanced properties; synthetic bioactive peptides/protein)
 
Molecular Microbiology Supervisors
  • Thorsten Allers (Archaeal genome biology)
     
  • Steve Atkinson (Bacterial virulence) 

  • Simon Avery (Fungal cell variation)

  • Ed Bolt (Genome engineering)

  • Matthias Brock (Control of fungal pathogens; Fungal secondary metabolism; Fungal human and plant pathogens; Lichen biochemistry; Biotechnological applications of fungi)

  • Ruth Griffin (Vaccine Biotechnology)

  • Stephan Heeb (Clinical and cellular microbiology of medically important bacteria - Pseudomonas aeruginosa and Staphylococcus aureus)

  • Nigel Minton (Clostridial gene technologies)

  • Neil Oldfield (Clinical and cellular microbiology of medically important bacteria - Neisseria species)

  • Christopher Penfold (Bacteriocin production by E. Coli; Anti-microbial peptides; Hybrid molecules)

  • Bill Wickstead (Trypanosome biology) 

  • Paul Williams (Cell-to-cell communication (quorum sensing); Discovery of new antibacterial agents and biofilm resistant polymers)

  • Klaus Winzer (Bacterial metabolism and physiology, Clostridia, CO-utilising bacteria, quorum-sensing, metabolic engineering, synthetic biology)

  • Karl Wooldridge (Molecular and cellular microbiology, bacterial protein secretion, and bacterial vaccines)

  • Ying Zhang (strain engineering; bioproducts from renewable sources; synthetic biology approaches to generate novel strains with advanced properties; synthetic bioactive peptides/protein)
 
 Molecular Biosciences Supervisors
  • Steve Alexander (Endogenous cannabinoid system, with particular focus on inflammation and pain)

  • Andrew Bennett (Neuroinflammation and metabolic dysfunction)

  • William Brown (The genetics and evolution of centromere assembly in vertebrates and fission yeast; Human mini-chromosome engineering)

  • Federico Dajas-Bailador (Signal integration and the regulation of protein levels in the axonal growth cone)

  • Claire Friel (Cytoskeletal Dynamics and the Mechanochemistry of Motor Proteins)

  • Marios Georgiou (Cancer biology; Cell morphogenisis)

  • Alistair Hume (Organelles and disease)

  • Ian Kerr (Mechanisms and structures of proteins involved in transmembrane flux)

  • Robert Layfield (Ubiquitin-mediated signalling and proteostasis; Paget's disease of bone - molecular mechanisms and ancient forms of the disorder; Neurodegenerative disorders - ALS and FTLD; Proteomic analyses - including of ancient proteins (paleoproteomics); Protein structure and function)

  • Lopa Leach (Regulation of vascular flow and barrier function in the human placenta in normal and compromised pregnancies)

  • Andrew Renault (Developmental biology)

  • Rita Tewari (Functional analysis of signalling pathways modulating malaria parasite development, cell division and parasite proliferation)

  • Uwe Vinkemeier (Cytokines; Signal transduction in myeloid cells)

  • Sally Wheatley (cell cycle, cell death and cance)

  • Bill Wickstead (Trypanosome biology) 
 
Biochemistry Supervisors
  • Steve Alexander (Endogenous cannabinoid system, with particular focus on inflammation and pain)

  • Andrew Bennett (Neuroinflammation and metabolic dysfunction)

  • Ed Bolt (Genome engineering)

  • Steve Briddon (Molecular Pharmacology of GPCRs; Fluorescence Correlation Spectroscopy; Single cell pharmacology; Live cell confocal microscopy; Advanced imaging approaches; Single cell calcium measurements; Cell microinjection; Radioligand binding; Second messenger assays; Western blotting and immunoprecipitation)
  • Matthias Brock (Control of fungal pathogens; Fungal secondary metabolism; Fungal human and plant pathogens; Lichen biochemistry; Biotechnological applications of fungi)

  • Claire Friel (Cytoskeletal Dynamics and the Mechanochemistry of Motor Proteins)

  • Marios Georgiou (Cancer biology; Cell morphogenisis)

  • Alistair Hume (Organelles and disease)

  • Ian Kerr (Mechanisms and structures of proteins involved in transmembrane flux)

  • Rob Lane (G protein-coupled receptors (GPCRs))

  • Robert Layfield (Ubiquitin-mediated signalling and proteostasis; Paget's disease of bone - molecular mechanisms and ancient forms of the disorder; Neurodegenerative disorders - ALS and FTLD; Proteomic analyses - including of ancient proteins (paleoproteomics); Protein structure and function)

  • Sebastian Serres (Development of a cutting-edge metabolic imaging method- called Dynamic Nuclear Polarisation 13C MR spectroscopy; Investigating metabolic changes associated with brain and musculoskeletal function in health and disease)

  • Dmitry Veprintsev (developing approaches for incorporation of protein and systems dynamics GPCRs into drug discovery)

  • Uwe Vinkemeier (Cytokines; Signal transduction in myeloid cells)

  • Sally Wheatley (cell cycle, cell death and cancer)
 
Biomedical Sciences Supervisors
  • Steve Alexander (Endogenous cannabinoid system, with particular focus on inflammation and pain)

  • Ed Bolt (Genome engineering)

  • Steve Briddon (Molecular Pharmacology of GPCRs; Fluorescence Correlation Spectroscopy; Single cell pharmacology; Live cell confocal microscopy; Advanced imaging approaches; Single cell calcium measurements; Cell microinjection; Radioligand binding; Second messenger assays; Western blotting and immunoprecipitation)

  • Marios Georgiou (Cancer biology; Cell morphogenisis)

  • Ruth Griffin (Vaccine Biotechnology)

  • Ian Kerr (Mechanisms and structures of proteins involved in transmembrane flux)

  • Nigel Minton (Clostridial gene technologies)

  • Christopher Penfold (Bacteriocin production by E. Coli; Anti-microbial peptides; Hybrid molecules)

  • Rebecca Trueman (Post-stroke recovery and the things that affect it such as age and infection;The mechanisms underlying post-stroke recovery)

  • Uwe Vinkemeier (Cytokines; Signal transduction in myeloid cells)

  • Sally Wheatley (cell cycle, cell death and cancer)
 

 

 

School of Life Sciences

University of Nottingham
Medical School
Queen's Medical Centre
Nottingham NG7 2UH

Contact us